Irvine Scientific Introduces PRIME-XV® T Cell CDM for Immunotherapy Applications

Jan 16, 2017 | Posted in Cell Therapy The first chemically-defined, animal component-free, cell culture medium for T cells SANTA ANA, California – January 17, 2017: Irvine Scientific, a worldwide leader in cell culture media development and manufacturing, today announced the introduction of PRIME-XV® T Cell CDM, the first commercially available chemically-defined, animal component-free medium... Read more

Illumina and Bio-Rad Launch Solution for Single-Cell Genomic Sequencing to Enable Robust Study of Complex Diseases

SAN DIEGO and HERCULES, Calif. — January 9, 2017 — Illumina, Inc. (NASDAQ: ILMN) and Bio‑Rad Laboratories, Inc. (NYSE: BIO)(NYSE: BIOb) today announced the launch of the Illumina® Bio-Rad® Single-Cell Sequencing Solution at the J.P. Morgan Healthcare Conference, San Francisco. The comprehensive solution is the first next-generation sequencing (NGS) workflow for single-cell analysis, providing researchers... Read more

Reliable and reproducible flow cytometry results

Miltenyi Biotec introduces the largest portfolio of recombinant antibodies optimized for flow cytometry – REAfinity™ Antibodies  BERGISCH GLADBACH, December 8, 2016 – Miltenyi Biotec has expanded its antibody portfolio and now offers more than 500 new recombinantly engineered antibodies – the REAfinity™ Antibodies optimized for flow cytometry. These antibodies display considerable advantages over conventional monoclonal antibodies... Read more

The course schedule has arrived! MACS® Academy is starting its new program

Bergisch Gladbach, 22. November 2016– Once again, the MACS® Academy is offering a comprehensive course program at its locations in Bergisch Gladbach, Germany and San Diego, USA, in 2017 – miltenyibiotec.com/macsacademy. The courses will focus on: Immunology, Stem Cell Research, Cardiology, Neuroscience, and advanced technologies including sample preparation, cell separation and flow cytometry. The MACS® Academy... Read more

GE Healthcare and Valneva Collaboration Delivers Optimized Cell Culture Medium for Vaccine Production

Chalfont St. Giles, UK and Lyon, France – 2 November, 2016 – GE Healthcare’s Life Sciences business and Valneva SE, a fully integrated vaccine biotech company, are sharing the results of a successful collaboration to optimize virus productivity in Valneva’s EB66® cell-line, a proprietary technology for the production of a wide variety of vaccines, including... Read more

Miltenyi Biotec acquires exclusive rights for the distribution and development of the viral transduction enhancer Vectofusin-1® from Genethon

Evry, France, and Bergisch Gladbach, Germany, September 28th, 2016 – Genethon, a leader in the field of gene therapy treatments for rare diseases, and Miltenyi Biotec, a global front-runner in cell processing and related technologies in cell therapy, have announced the execution of an exclusive license to the patents and trademarks for the development and commercialization... Read more

Cellular Dynamics Announces Launch of iCell® Hepatoblasts to Enable Research into Therapies That Stimulate Liver Regeneration

MADISON, Wis., September 22, 2016 – Cellular Dynamics International, Inc. (CDI), a FUJIFILM company, today announced the launch of iCell® Hepatoblasts, liver progenitor cells generated from human induced pluripotent stem cells (iPSCs). These cells show promise for liver regeneration therapy research by enabling researchers to identify molecules capable of stimulating liver progenitor cell proliferation and... Read more

CE marked MACS® IVD Antibodies by Miltenyi Biotec – Compliant with IVDD and produced according to ISO 13485

BERGISCH GLADBACH, 19. September 2016 – Miltenyi Biotec has expanded its assortment of antibodies with a series of CE marked in vitro-diagnostic medical devices – MACS® IVD Antibodies. They can be used in both clinical flow cytometry and in the quality control of cellular products for translational research. The renowned biotech company from Bergisch Gladbach... Read more

Cellular Dynamics to Realign Business Units to Better Serve Therapeutic and Life Science Customers

MADISON, WIS, September 1, 2016 – Cellular Dynamics International, Inc. (CDI), a FUJIFILM company, today announced that effective September 1, 2016 the company operations will be divided into two equally important business units. Emile Nuwaysir, PhD, President and Chief Operating Officer of CDI, will lead the Therapeutics Business Unit. The Life Science business unit will be led by... Read more

Johns Hopkins and Salk Co-lead $15 Million Initiative to Unravel Bipolar Disorder and Schizophrenia

Order Contact Careers Account Log In/Register Why CDI Partners & Providers Our Technology Cellular Therapy Drug Discovery Health & Nutrition Stem Cell Banking Products & Services iCell Products iCell Cardiomyocytes iCell Cardiomyocytes2 iCell Cardiac Progenitor Cells iCell Neurons iCell Astrocytes iCell DopaNeurons iCell GlutaNeurons iCell Hepatocytes 2.0 iCell Hepatoblasts iCell Skeletal Myoblasts iCell Endothelial Cells... Read more